NanoBio Nasal Antiseptic Launch Accelerated As COVID19 Spikes Demand For Personal Sanitizers
NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers
15:47 EDT 5 Apr 2020 |
SCRIP
“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient...
More From BioPortfolio on "NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers"